Related Experiment Video
Updated: May 21, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Cytotoxic T lymphocytes: Sniping cancer stem cells
Yoshihiko Hirohashi1, Toshihiko Torigoe, Satoko Inoda
1Department of Pathology; Sapporo Medical University School of Medicine; Sapporo, Japan.
Oncoimmunology
|June 22, 2012
Summary
Cancer stem cells (CSCs), resistant to therapy, may be eradicated by cytotoxic T lymphocytes (CTLs). This approach offers a promising strategy for curing cancer by targeting these resilient cells.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Cancer stem cells (CSCs) or cancer-initiating cells (CICs) represent a small subpopulation of cancer cells.
- CSCs/CICs possess significant tumor-initiating capabilities.
- These cells exhibit resistance to conventional cancer therapies, posing a major challenge in cancer treatment.
Purpose of the Study:
- To explore novel therapeutic strategies for eradicating cancer stem cells (CSCs/CICs).
- To investigate the potential of cytotoxic T lymphocytes (CTLs) as a means to eliminate CSCs/CICs.
Main Methods:
- This study focuses on the conceptual framework and potential of CTLs against CSCs/CICs.
- Further research would involve in vitro and in vivo models to assess CTL efficacy.
Main Results:
- Cytotoxic T lymphocytes (CTLs) are identified as a potential therapeutic avenue for targeting CSCs/CICs.
- The inherent resistance of CSCs/CICs to current treatments highlights the need for innovative approaches like CTL-based therapy.
Conclusions:
- Eradication of cancer stem cells (CSCs/CICs) is crucial for achieving a definitive cancer cure.
- Cytotoxic T lymphocytes (CTLs) present a promising strategy for overcoming CSC/CIC resistance and improving cancer treatment outcomes.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...